Investigational Nonopioid VX-548 Reduces Moderate to Severe Postoperative Pain in Late-Stage Clinical TrialsBy MediApril 19, 2024 In 2 pivotal phase 3 randomized clinical trials, the investigational selective NaVThe 1,8-blocker was associated with a statistically significant improvement in pain intensity and a clinically…
